理赔数据无法准确评估神经科医生在癫痫诊疗中的价值
该研究利用2001至2016年United Healthcare理赔数据识别新发癫痫患者,经倾向评分匹配形成3400例就诊神经科者与3400例对照。结果显示就诊神经科者癫痫相关急诊就诊、住院、医疗费用及脑电图和癫痫手术均更高,作者认为行政理赔数据比较可能受疾病严重程度混杂。
要点
- 就诊神经科的新发癫痫患者后续急诊、住院和费用更高,可能反映病情更重。
- 理赔数据缺乏病情严重度等临床信息,难以据此评价神经科诊疗价值。
- 需将患者中心结局与理赔数据链接以评估异质性人群的诊疗价值。
核心结论
- 就诊神经科的新发癫痫患者后续医疗服务使用、医疗费用和诊疗升级均高于对照,但该比较可能因病例疾病严重程度而存在混杂。
- 作者认为将患者中心结局与理赔数据链接可能提供临床分辨率,以评估异质性人群中的诊疗价值。
研究设计与样本
- 基于2001至2016年United Healthcare参保者理赔数据识别新发癫痫患者,以癫痫/惊厥诊断编码及后续2年内抗癫痫药处方定义,且前2年不满足上述标准。
- 将新发诊断后1年内因癫痫就诊神经科者定义为病例,并采用倾向评分匹配构建对照队列,最终纳入3400例病例和3400例对照。
- 主要结局为癫痫相关急诊就诊和住院,次要结局包括费用(癫痫相关、非癫痫相关、抗癫痫药)和诊疗升级(含脑电图评估和癫痫手术)。
主要发现
- 病例组癫痫相关急诊就诊比例高于对照(第1年:5.9% vs 2.3%,p < 0.001)。
- 病例组癫痫相关住院比例高于对照(第1年:2.1% vs 0.7%,p < 0.001)。
- 病例组癫痫诊疗总医疗费用、非癫痫医疗费用和抗癫痫药费用均更高(p ≤ 0.001)。
- 病例组接受脑电图评估和癫痫手术更常见(p ≤ 0.001)。
临床怎么用
- 解读理赔数据中神经科就诊与高利用率的关联时需警惕病情严重度混杂,不宜直接推断诊疗价值。
- 评估癫痫诊疗质量应结合患者中心结局与临床严重度信息,而非仅依赖行政理赔指标。
局限性
- 作者指出该行政理赔数据的比较很可能受到病例疾病严重程度混杂,非癫痫医疗费用更高提示病例组病情更重。
- 摘要未报告理赔数据缺乏临床严重度、癫痫类型和发作控制等信息的具体影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the association of a neurologist visit with health care use and cost outcomes for patients with incident epilepsy. METHODS: Using health care claims data for individuals insured by United Healthcare from 2001 to 2016, we identified patients with incident epilepsy. The population was defined by an epilepsy/convulsion diagnosis code (ICD codes 345.xx/780.3x, G40.xx/R56.xx), an antiepileptic prescription filled within the succeeding 2 years, and neither criterion met in the 2 preceding years. Cases were defined as patients who had a neurologist encounter for epilepsy within 1 year after an incident diagnosis; a control cohort was constructed with propensity score matching. Primary outcomes were emergency room (ER) visits and hospitalizations for epilepsy. Secondary outcomes included measures of cost (epilepsy related, not epilepsy related, and antiepileptic drugs) and care escalation (including EEG evaluation and epilepsy surgery). RESULTS: After participant identification and propensity score matching, there were 3,400 cases and 3,400 controls. Epilepsy-related ER visits were more likely for cases than controls (year 1: 5.9% vs 2.3%, p < 0.001), as were hospitalizations (year 1: 2.1% vs 0.7%, p < 0.001). Total medical costs for epilepsy care, nonepilepsy care, and antiepileptic drugs were greater for cases (p ≤ 0.001). EEG evaluation and epilepsy surgery occurred more commonly for cases (p ≤ 0.001). CONCLUSIONS: Patients with epilepsy who visited a neurologist had greater subsequent health care use, medical costs, and care escalation than controls. This comparison using administrative claims is plausibly confounded by case disease severity, as suggested by higher nonepilepsy care costs. Linking patient-centered outcomes to claims data may provide the clinical resolution to assess care value within a heterogeneous population.
引用
- Hill CE, Lin CC, Burke JF, et al. Claims data analyses unable to properly characterize the value of neurologists in epilepsy care. Neurology. 2019. PMID: 30674587. doi:10.1212/WNL.0000000000007004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。